Long-term Safety of Protopic in Atopic Eczema

Clinical trial NCT00560378 · COMPLETED

Trial details

NCT number: NCT00560378
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dermatitis, Atopic Eczema, Atopic

Start date: 1998-06-01
Enrollment: 789

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.